Drug intelligence / Profile preview

Prurisedán

Development stage
Unknown
Lead developer
Andromaco
Modality
Small Molecules
Administration
Topical
01

Overview

**Prurisedán** is an Argentine topical antipruritic pharmaceutical brand family marketed by Andrómaco, rather than one chemically uniform drug. The currently identified presentations include an over-the-counter cream containing diphenhydramine hydrochloride plus calamine, an over-the-counter clear lotion containing diphenhydramine hydrochloride plus zinc oxide, and a prescription powder containing boric acid plus zinc oxide. The diphenhydramine-containing products provide local antihistaminic relief of itch, while calamine or zinc oxide provide protective, soothing, and drying effects; the powder formulation is described as antipruritic, antiseptic, and astringent, with boric acid contributing local bacteriostatic activity. The product line is used for symptomatic relief of pruritus and selected superficial inflammatory or irritant skin conditions, including insect bites, contact dermatitis, sunburn, urticaria, miliaria, and moist or blistering pruritic lesions. ([prurisedan.com.ar](https://www.prurisedan.com.ar/))

Brand names
Prurisedán
Other names
Prurisedan
02

Targets

5-HT2 (5-HT2 receptor family)HRH1 (Histamine H1 Receptor)mAChR (Muscarinic acetylcholine receptors)

Beyond the preview

Go deeper on Prurisedán.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Prurisedán.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call